Drug Therapy Optimization
Drug Therapy Optimization - Related Videos
01:28
Drug Therapy
0 Views •
2025
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations. Antianxiety Medications
11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
0 Views •
Cited by 7 •
2017
This protocol describes the fabrication of elastic 3D macroporous microcryogels by integrating microfabrication with cryogelation technology. Upon loading with cells, 3D microtissues are generated, which can be readily injected in vivo to facilitate regenerative therapy or assembled into arrays for in vitro high-throughput drug screening.
01:26
Drug Administration and Therapy Phases: Overview
0 Views •
2024
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic. The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions. The pharmacokinetic phase...
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
0 Views •
Cited by 4 •
2016
Methods to evaluate the efficacy and toxicity of RNA molecules targeting post-integration steps of the HIV-1 replication cycle are described. These methods are useful for screening new molecules and optimizing the format of existing ones.
10:13
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
0 Views •
Cited by 29 •
2015
Many types of human brain tumors are localized to specific regions within the brain and are difficult to grow in culture. This protocol addresses the role of tumor microenvironment and investigates new drug treatments by analyzing fluorescent primary brain tumor cells growing in an organotypic mouse brain slice.
FAQs
Pharmacokinetic and pharmacodynamic principles provide complementary perspectives for refining treatment. Considering both helps clinicians connect medicine selection and dosing with the intended therapeutic effect. Patient-specific information, including organ function, drug interactions, treatment response, and adherence, helps determine whether the regimen remains suitable as care progresses.
Organ function can influence how safely a medicine can be used, while interactions are among the patient-specific factors considered in drug selection and adjustment. Reviewing these factors helps reduce preventable medication-related harm and supports a more appropriate regimen for the individual patient.
Therapeutic drug monitoring supplies information that can be combined with laboratory results, treatment response, and other patient-specific findings. Clinicians use this ongoing assessment to judge whether drug choice, dose, timing, or duration should be refined as the patient's condition changes.
A review considers the selected medicine, its dose, timing, and duration alongside drug interactions, organ function, laboratory results, treatment response, and adherence. Clinicians then reassess these inputs as the patient's condition changes. This continuing cycle supports safer prescribing and helps identify when treatment requires adjustment.
Observed response shows whether therapy is producing the intended benefit, while adherence indicates how consistently the planned regimen is followed. Considering both prevents clinicians from evaluating drug choice or dose in isolation. Their review can guide adjustments and help address treatment failure.
The approach can help limit treatment failure and antimicrobial resistance by linking medicine selection and adjustments to patient-specific information, treatment response, and ongoing assessment. It also supports safer prescribing and reduces preventable medication-related harm, making optimization relevant to clinical decisions involving anti-infective therapy.